Yiheng Du

441 total citations
26 papers, 284 citations indexed

About

Yiheng Du is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Yiheng Du has authored 26 papers receiving a total of 284 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 8 papers in Pulmonary and Respiratory Medicine and 5 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Yiheng Du's work include Epigenetics and DNA Methylation (4 papers), Cancer-related molecular mechanisms research (4 papers) and Ferroptosis and cancer prognosis (3 papers). Yiheng Du is often cited by papers focused on Epigenetics and DNA Methylation (4 papers), Cancer-related molecular mechanisms research (4 papers) and Ferroptosis and cancer prognosis (3 papers). Yiheng Du collaborates with scholars based in China, United States and Taiwan. Yiheng Du's co-authors include Yunming Li, Bing Li, Hanfeng Yang, Xiaoxue Xu, Haitao Liu, Tianyou Luo, Jiang Yu, Jin Cao, Xiang Jiang and Qiyong Gong and has published in prestigious journals such as Advanced Materials, SHILAP Revista de lepidopterología and Nano Letters.

In The Last Decade

Yiheng Du

24 papers receiving 279 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yiheng Du China 9 117 76 55 48 46 26 284
Michael Shin United States 10 155 1.3× 53 0.7× 59 1.1× 19 0.4× 59 1.3× 14 297
Asghar Naqvi Canada 10 113 1.0× 110 1.4× 59 1.1× 23 0.5× 89 1.9× 36 362
Mariarosa Pascale Switzerland 13 176 1.5× 81 1.1× 56 1.0× 30 0.6× 90 2.0× 15 373
Zhigui Ma China 6 45 0.4× 60 0.8× 40 0.7× 28 0.6× 95 2.1× 9 308
Ezgi Güler Türkiye 11 91 0.8× 48 0.6× 61 1.1× 24 0.5× 59 1.3× 41 283
Yu‐Wei Lin Taiwan 11 146 1.2× 55 0.7× 90 1.6× 30 0.6× 69 1.5× 33 384
Johannes Laimer Austria 9 89 0.8× 49 0.6× 46 0.8× 22 0.5× 89 1.9× 28 324
Veronica Ricci Italy 12 113 1.0× 90 1.2× 39 0.7× 48 1.0× 88 1.9× 25 381
Guofeng Ma China 11 85 0.7× 60 0.8× 110 2.0× 51 1.1× 15 0.3× 23 354
Elizabeth Philipone United States 12 105 0.9× 101 1.3× 68 1.2× 62 1.3× 99 2.2× 55 475

Countries citing papers authored by Yiheng Du

Since Specialization
Citations

This map shows the geographic impact of Yiheng Du's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yiheng Du with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yiheng Du more than expected).

Fields of papers citing papers by Yiheng Du

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yiheng Du. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yiheng Du. The network helps show where Yiheng Du may publish in the future.

Co-authorship network of co-authors of Yiheng Du

This figure shows the co-authorship network connecting the top 25 collaborators of Yiheng Du. A scholar is included among the top collaborators of Yiheng Du based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yiheng Du. Yiheng Du is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Yao, Bohan Yang, Shijie Liu, et al.. (2025). Metagenomic next-generation sequencing for lung cancer low respiratory tract infections diagnosis and characterizing microbiome features. Frontiers in Cellular and Infection Microbiology. 14. 1518199–1518199. 2 indexed citations
2.
Zeng, Kaizhu, Peiyuan Gao, Litao Yan, et al.. (2025). Molybdenum‐Enriched Mo 0.5 Ru 0.5 O 2 Nanoparticles for Efficient and Stable Oxygen Evolution Reaction. Advanced Materials. e20210–e20210.
3.
Huang, Zhennan, Tangyuan Li, Boyang Li, et al.. (2025). Phase Changes of Multielemental Alloy Nanoparticles at Elevated Temperatures. ACS Nano. 19(13). 13457–13465. 1 indexed citations
4.
5.
Wu, Yi‐Long, Zhichen Wang, Y. Cheng, et al.. (2024). 1255MO A phase II safety and efficacy study of PM8002/BNT327 in combination with chemotherapy in patients with EGFR-mutated non-small cell lung cancer (NSCLC). Annals of Oncology. 35. S804–S804. 6 indexed citations
6.
7.
Wang, Qinlong, Yu Tang, Ziling Huang, et al.. (2024). DLRover-RM: Resource Optimization for Deep Recommendation Models Training in the Cloud. Proceedings of the VLDB Endowment. 17(12). 4130–4144. 1 indexed citations
8.
Ye, Linlin, Xiao‐Shan Wei, Yiran Niu, et al.. (2023). Circular RNA circFBXO7 attenuates non-small cell lung cancer tumorigenesis by sponging miR-296-3p to facilitate KLF15-mediated transcriptional activation of CDKN1A. Translational Oncology. 30. 101635–101635. 8 indexed citations
9.
Xiong, Rui, Yiheng Du, Sili Chen, et al.. (2023). Hypermethylation of the ADIRF promoter regulates its expression level and is involved in NNK-induced malignant transformation of lung bronchial epithelial cells. Archives of Toxicology. 97(12). 3243–3258. 4 indexed citations
10.
Zhou, Jiaxin, Hongxing Zou, Yongqin Liu, et al.. (2022). Acute cytotoxicity test of PM2.5, NNK and BPDE in human normal bronchial epithelial cells: A comparison of a co-culture model containing macrophages and a mono-culture model. Toxicology in Vitro. 85. 105480–105480. 5 indexed citations
11.
Wang, Zi-Hao, Pei Zhang, Yiheng Du, et al.. (2022). High-risk early-stage lung adenocarcinoma patients are identified by an immune-related circadian clock gene signature. Journal of Thoracic Disease. 14(10). 3748–3761. 2 indexed citations
12.
Du, Yiheng, Xiang Jiang, Bo Wang, et al.. (2021). The cancer‐associated fibroblasts related gene CALD1 is a prognostic biomarker and correlated with immune infiltration in bladder cancer. Cancer Cell International. 21(1). 283–283. 36 indexed citations
13.
Du, Yiheng, Bo Wang, Xiang Jiang, et al.. (2021). Identification and Validation of a Stromal EMT Related LncRNA Signature as a Potential Marker to Predict Bladder Cancer Outcome. Frontiers in Oncology. 11. 620674–620674. 16 indexed citations
14.
Ma, Yanyun, Quan Li, Yiheng Du, et al.. (2020). Oncogenic Genetic Alterations in Non-Small-Cell Lung Cancer (NSCLC) in Southwestern China. SHILAP Revista de lepidopterología. 1 indexed citations
15.
Li, Bing, et al.. (2019). CT-guided core needle biopsy of small (≤20 mm) subpleural pulmonary lesions: value of the long transpulmonary needle path. Clinical Radiology. 74(7). 570.e13–570.e18. 6 indexed citations
16.
Wu, Wenbo, Jian Zhang, Yiheng Du, et al.. (2017). Human Umbilical Cord Mesenchymal Stem Cells Overexpressing Nerve Growth Factor Ameliorate Diabetic Cystopathy in Rats. Neurochemical Research. 42(12). 3537–3547. 17 indexed citations
17.
Wu, Wenbo, Wei Wang, Yiheng Du, et al.. (2016). MicroRNA-3713 regulates bladder cell invasion via MMP9. Scientific Reports. 6(1). 32374–32374. 9 indexed citations
18.
Li, Yunming, Yiheng Du, Tianyou Luo, et al.. (2015). Usefulness of normal saline for sealing the needle track after CT-guided lung biopsy. Clinical Radiology. 70(11). 1192–1197. 45 indexed citations
19.
Xu, Xiaoxue, Bing Li, Hanfeng Yang, et al.. (2014). Can diffusion-weighted imaging be used to differentiate brain abscess from other ring-enhancing brain lesions? A meta-analysis. Clinical Radiology. 69(9). 909–915. 43 indexed citations
20.
Li, Yunming, et al.. (2013). Factors influencing diagnostic yield of CT-guided percutaneous core needle biopsy for bone lesions. Clinical Radiology. 69(1). e43–e47. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Michael Shin Breakdown of academic impact, for papers by Asghar Naqvi Breakdown of academic impact, for papers by Mariarosa Pascale Breakdown of academic impact, for papers by Zhigui Ma Breakdown of academic impact, for papers by Ezgi Güler Breakdown of academic impact, for papers by Yu‐Wei Lin Breakdown of academic impact, for papers by Johannes Laimer Breakdown of academic impact, for papers by Veronica Ricci Breakdown of academic impact, for papers by Guofeng Ma Breakdown of academic impact, for papers by Elizabeth Philipone
Rankless by CCL
2026